Monday, February 28, 2022
Taro Pharmaceutical Industries Ltd. today announced the completion of its acquisition of Alchemee, formerly The Proactiv Company (TPC), from Galderma. The acquisition includes Alchemee’s business and assets worldwide, including the Proactiv® brand.
“This acquisition demonstrates Taro’s commitment to strengthening our position in the over-the-counter dermatology space,” said Uday Baldota, Taro’s CEO. “In addition to adding Proactiv® to our product portfolio, we are also gaining the omni-channel marketing capabilities and expertise of the Alchemee team. We look forward to working with them to continue Proactiv®’s legacy as an iconic brand synonymous with acne care.”
Alchemee's flagship brand, Proactiv, is America’s #1 acne routine1 and has been used and trusted by millions around the world for more than 25 years.
“We are excited for Alchemee and its marquee brand, Proactiv®, to join the expansive Taro portfolio of prescription and over-the-counter dermatology products,” said Shannon Pappas, Global Head of Alchemee. “This strategic move further positions Alchemee for continued growth in the skincare space.”